Grant: Master's Award: Canada Graduate Scholarships
McGill University
$27,000.00
Characterization of Placenta-Derived Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Placental Malaria
FY 2024-25
Summary
Placental malaria is caused byPlasmodium falciparum infected red blood cells (iRBCs) binding to the placenta, leading to detrimental fetal outcomes including miscarriage and low birth weight. Adhesion of iRBCs to the placenta is mediated by the parasite protein VAR2CSA binding to syndecan-1 (SDC1), a crucial receptor on the placenta surface. The unknown downstream effects of this interaction on SDC1 function and lack of early diagnostic tools for placental malaria remain significant challenges.Extracellular vesicles (EVs) are small membrane-bound particles involved in cell-to-cell communication. They contain fingerprint-like payloads that reflect the origin and physiological state of the origin cell, making them promising biomarkers for the early detection of placental malaria.Hypothesis 1: Placental cells, upon exposure to iRBCs, release EVs (P-EVs) containing specific proteins and RNA into the maternal bloodstream. These molecules could serve as biomarkers for the early diagnosis of PM.We will expose placental tissue models to iRBCs and use proteomics and transcriptomics to catalogue the molecular cargo of the P-EVs and identify likely biomarkers.Hypothesis 2: SDC1 is present within P-EVs and interacts with VAR2CSA on iRBCs, potentially inhibiting their binding to the ST and acting as a protective mechanism against parasite binding.We will use in vitro models of placenta tissue exposed to iRBCs to study the role of SDC1 in infection. Flow cytometry and inhibition assays will be implemented to identify SDC1 within the EVs and reveal it role in parasite binding to the placenta.The overarching goal of this research project is to identify placental malaria biomarkers present in P-EVs and to identify the role of SDC1 in the binding of iRBCs.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
530267
Name
Campbell Kirsten
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of Placenta-Derived Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Placental Malaria
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarker Discovery; Extracellular Vesicles; Placental Malaria; Syndecan-1
Abstract
Placental malaria is caused byPlasmodium falciparum infected red blood cells (iRBCs) binding to the placenta, leading to detrimental fetal outcomes including miscarriage and low birth weight. Adhesion of iRBCs to the placenta is mediated by the parasite protein VAR2CSA binding to syndecan-1 (SDC1), a crucial receptor on the placenta surface. The unknown downstream effects of this interaction on SDC1 function and lack of early diagnostic tools for placental malaria remain significant challenges.Extracellular vesicles (EVs) are small membrane-bound particles involved in cell-to-cell communication. They contain fingerprint-like payloads that reflect the origin and physiological state of the origin cell, making them promising biomarkers for the early detection of placental malaria.Hypothesis 1: Placental cells, upon exposure to iRBCs, release EVs (P-EVs) containing specific proteins and RNA into the maternal bloodstream. These molecules could serve as biomarkers for the early diagnosis of PM.We will expose placental tissue models to iRBCs and use proteomics and transcriptomics to catalogue the molecular cargo of the P-EVs and identify likely biomarkers.Hypothesis 2: SDC1 is present within P-EVs and interacts with VAR2CSA on iRBCs, potentially inhibiting their binding to the ST and acting as a protective mechanism against parasite binding.We will use in vitro models of placenta tissue exposed to iRBCs to study the role of SDC1 in infection. Flow cytometry and inhibition assays will be implemented to identify SDC1 within the EVs and reveal it role in parasite binding to the placenta.The overarching goal of this research project is to identify placental malaria biomarkers present in P-EVs and to identify the role of SDC1 in the binding of iRBCs.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Campbell, Kirsten
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~